EN
CN
Milestones
The new process improvement research of injection grade lansoprazole won the new product and new technology certificate of Guangxi Zhuang Autonomous Region.
2019
New formulation and API workshops passed GMP inspection. The intellectual property management system was authenticated.
2018
Acquired land and infrastructure from Guangxi Kelun Pharmaceutical Co., Ltd.
2017
The new warehouse and tank yard were completed.
2016
Office building construction finished.
2015
Initiated plant extension and reconstruction project; obtained Lansoprazole CEP certificate.
2014
We are recognized as a national high-tech enterprise.
2013
We passed 3 GMP inspections for capsules, granules, ointment, and Venlafaxine Hydrochloride API.
2011
Our first formulation product, Valsartan Dispersible Tablets, has passed the GMP inspection.
2009
Founded in Lingchuan Guilin, passed GMP inspection for Lansoprazole API.
2005